For this purpose, we measured CD3+HLA-DR+, CD3+CD4+, and CD3+CD8+ EV levels in sera from patients with EBV infection, AD, RA, and OA, and they were compared with those from healthy subjects. This evidence concerns the gene CD8A and Alzheimer disease.